Terms: = Sarcomas AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Treatment
29 results:
1. Network pharmacology and molecular docking to explore the mechanism of Sheng Xue Bao mixture against iron deficiency anemia.
Wang Y; Qinqin H; Wang H; Zhang H; Zhang X; Liu W; Xiang Z; Gu Y
Medicine (Baltimore); 2023 Sep; 102(37):e35012. PubMed ID: 37713882
[TBL] [Abstract] [Full Text] [Related]
2. Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high-volume cancer center.
Bertuzzi AF; Grimaudo MS; Laffi A; Giordano L; Gennaro N; Cariboni U; Siracusano LV; Quagliuolo V; Colombo P; Federico D; Renne SL; Specchia C; Cananzi F; Marrari A; Navarria P; Daolio PA; Bastoni S; Santoro A
Cancer Med; 2023 Aug; 12(15):16254-16263. PubMed ID: 37366268
[TBL] [Abstract] [Full Text] [Related]
3. Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
Hattinger CM; Casotti C; Patrizio MP; Luppi S; Fantoni L; Scotlandi K; Ibrahim T; Serra M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233089
[TBL] [Abstract] [Full Text] [Related]
4. Deviation from delivery of radiation therapy to childhood cancer patients: A retrospective audit.
Agrawal R; Goel V; Anand A; Arora RS
Pediatr Blood Cancer; 2022 Feb; 69(2):e29462. PubMed ID: 34842336
[TBL] [Abstract] [Full Text] [Related]
5. Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data.
Dudnik E; Moskovitz M; Rottenberg Y; Lobachov A; Mandelboim R; Shochat T; Urban D; Wollner M; Nechushtan H; Rotem O; Zer A; Daher S; Bar J;
Oncoimmunology; 2021 Jan; 10(1):1865653. PubMed ID: 33552685
[TBL] [Abstract] [Full Text] [Related]
6. Pathogenic Germline Mutations in DNA Repair Genes in Combination With Cancer treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer.
Qin N; Wang Z; Liu Q; Song N; Wilson CL; Ehrhardt MJ; Shelton K; Easton J; Mulder H; Kennetz D; Edmonson MN; Rusch MC; Downing JR; Hudson MM; Nichols KE; Zhang J; Robison LL; Yasui Y
J Clin Oncol; 2020 Aug; 38(24):2728-2740. PubMed ID: 32496904
[TBL] [Abstract] [Full Text] [Related]
7. An Age Stratified Analysis of the Access to Care Continuum Across Three Tumor Groups: Are There Delays for AYA?
Pettit T; Sue L; Waugh V; Ballantine K; Gardner K; Bremer L; Pemberton L; Allison L; Adams S; Chou E; Spearing R
J Adolesc Young Adult Oncol; 2019 Aug; 8(4):402-409. PubMed ID: 30912693
[No Abstract] [Full Text] [Related]
8. The effect of ERCC1 and ercc2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M
BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176
[TBL] [Abstract] [Full Text] [Related]
9. VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma.
Moon JY; Baek SW; Ryu H; Choi YS; Song IC; Yun HJ; Jo DY; Kim S; Lee HJ
Medicine (Baltimore); 2017 Jan; 96(4):e5942. PubMed ID: 28121937
[TBL] [Abstract] [Full Text] [Related]
10. Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
Hattinger CM; Biason P; Iacoboni E; Gagno S; Fanelli M; Tavanti E; Vella S; Ferrari S; Roli A; Roncato R; Giodini L; Scotlandi K; Picci P; Toffoli G; Serra M
Oncotarget; 2016 Sep; 7(38):61970-61987. PubMed ID: 27566557
[TBL] [Abstract] [Full Text] [Related]
11. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
[TBL] [Abstract] [Full Text] [Related]
12. Social inequalities and cancer: can the European deprivation index predict patients' difficulties in health care access? a pilot study.
Moriceau G; Bourmaud A; Tinquaut F; Oriol M; Jacquin JP; Fournel P; Magné N; Chauvin F
Oncotarget; 2016 Jan; 7(1):1055-65. PubMed ID: 26540571
[TBL] [Abstract] [Full Text] [Related]
13. Influence of ercc2 gene polymorphisms on the treatment outcome of osteosarcoma.
Liu ZF; Asila AL; Aikenmu K; Zhao J; Meng QC; Fang R
Genet Mol Res; 2015 Oct; 14(4):12967-72. PubMed ID: 26505449
[TBL] [Abstract] [Full Text] [Related]
14. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Wang MJ; Zhu Y; Guo XJ; Tian ZZ
Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
[TBL] [Abstract] [Full Text] [Related]
15. Investigation of ERCC1 and ercc2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma.
Zhang Q; Lv LY; Li BJ; Zhang J; Wei F
Genet Mol Res; 2015 Sep; 14(3):11235-41. PubMed ID: 26400354
[TBL] [Abstract] [Full Text] [Related]
16. Association between ERCC1 and ercc2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma.
Cao ZH; Yin HP; Jiang N; Yu B
Genet Mol Res; 2015 Aug; 14(3):10145-51. PubMed ID: 26345951
[TBL] [Abstract] [Full Text] [Related]
17. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.
Ji WP; He NB
Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792
[TBL] [Abstract] [Full Text] [Related]
18. Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma.
Goričar K; Kovač V; Jazbec J; Zakotnik B; Lamovec J; Dolžan V
Cancer Epidemiol; 2015 Apr; 39(2):182-8. PubMed ID: 25592234
[TBL] [Abstract] [Full Text] [Related]
19. Time to diagnosis of Ewing tumors in children and adolescents is not associated with metastasis or survival: a prospective multicenter study of 436 patients.
Brasme JF; Chalumeau M; Oberlin O; Valteau-Couanet D; Gaspar N
J Clin Oncol; 2014 Jun; 32(18):1935-40. PubMed ID: 24841977
[TBL] [Abstract] [Full Text] [Related]
20. A systematic review of time to diagnosis in children and young adults with cancer.
Lethaby CD; Picton S; Kinsey SE; Phillips R; van Laar M; Feltbower RG
Arch Dis Child; 2013 May; 98(5):349-55. PubMed ID: 23476000
[TBL] [Abstract] [Full Text] [Related]
[Next]
